99 related articles for article (PubMed ID: 16621418)
1. Physicochemical characterization of meloxicam-mannitol binary systems.
Nassab PR; Rajkó R; Szabó-Révész P
J Pharm Biomed Anal; 2006 Jun; 41(4):1191-7. PubMed ID: 16621418
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo investigations on the binary meloxicam-mannitol system.
Nassab PR; Blazsó G; Nyári T; Falkay G; Szabó-Révész P
Pharmazie; 2008 Apr; 63(4):319-20. PubMed ID: 18468395
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.
Naidu NB; Chowdary KP; Murthy KV; Satyanarayana V; Hayman AR; Becket G
J Pharm Biomed Anal; 2004 Apr; 35(1):75-86. PubMed ID: 15030882
[TBL] [Abstract][Full Text] [Related]
4. Analysis of co-spray-dried meloxicam-mannitol systems containing crystalline microcomposites.
Pomázi A; Ambrus R; Sipos P; Szabó-Révész P
J Pharm Biomed Anal; 2011 Sep; 56(2):183-90. PubMed ID: 21652159
[TBL] [Abstract][Full Text] [Related]
5. Self-modeling curve resolution method applied for the evaluation of dissolution testing data: a case study of meloxicam-mannitol binary systems.
Rajkó R; Nassab PR; Szabó-Révész P
Talanta; 2009 Jul; 79(2):268-74. PubMed ID: 19559876
[TBL] [Abstract][Full Text] [Related]
6. [Stability testing of meloxicam-containing microcomposites for inhalation].
Pomázi A; Ambrus R; Szabóné Révész P
Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
[TBL] [Abstract][Full Text] [Related]
7. Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam.
Bashiri-Shahroodi A; Nassab PR; Szabó-Révész P; Rajkó R
Drug Dev Ind Pharm; 2008 Jul; 34(7):781-8. PubMed ID: 18612916
[TBL] [Abstract][Full Text] [Related]
8. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam.
Shazly G; Badran M; Zoheir K; Alomrani A
Pak J Pharm Sci; 2015 Jan; 28(1):103-11. PubMed ID: 25553688
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.
Noolkar SB; Jadhav NR; Bhende SA; Killedar SG
AAPS PharmSciTech; 2013 Jun; 14(2):569-77. PubMed ID: 23483432
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30.
El-Badry M; Fathy M
Drug Dev Ind Pharm; 2006 Feb; 32(2):141-50. PubMed ID: 16537195
[TBL] [Abstract][Full Text] [Related]
11. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
[TBL] [Abstract][Full Text] [Related]
12. Analysis of polymorphic contamination in meloxicam raw materials and its effects on the physicochemical quality of drug product.
Jacon Freitas JT; Santos Viana OMM; Bonfilio R; Doriguetto AC; de Araújo MB
Eur J Pharm Sci; 2017 Nov; 109():347-358. PubMed ID: 28844846
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
[TBL] [Abstract][Full Text] [Related]
14. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
Iurian S; Bogdan C; Tomuță I; Szabó-Révész P; Chvatal A; Leucuța SE; Moldovan M; Ambrus R
Eur J Pharm Sci; 2017 Jun; 104():356-365. PubMed ID: 28435075
[TBL] [Abstract][Full Text] [Related]
15. The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam.
Bartos C; Szabó-Révész P; Bartos C; Katona G; Jójárt-Laczkovich O; Ambrus R
Molecules; 2016 Apr; 21(4):507. PubMed ID: 27110752
[TBL] [Abstract][Full Text] [Related]
16. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
[TBL] [Abstract][Full Text] [Related]
17. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
18. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188.
Ghareeb MM; Abdulrasool AA; Hussein AA; Noordin MI
AAPS PharmSciTech; 2009; 10(4):1206-15. PubMed ID: 19862626
[TBL] [Abstract][Full Text] [Related]
19. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population.
Pathak D; Dahiya S; Pathak K
Acta Pharm; 2008 Mar; 58(1):99-110. PubMed ID: 18337211
[TBL] [Abstract][Full Text] [Related]
20. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
Alladi S; Shastri NR
Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
